Ingrid Glimelius

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 130 publications

No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma.

No association between temozolomide maintenance and survival after first-line treatment in primary CNS lymphoma.

Journal: HemaSphere

Published: May 21, 2026

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.

Journal: European journal of haematology

Published: May 14, 2026

Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients.

Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients.

Journal: Leukemia & lymphoma

Published: March 04, 2026

High time for risk-adapted treatment in mantle cell lymphoma.

High time for risk-adapted treatment in mantle cell lymphoma.

Journal: The Lancet. Haematology

Published: February 15, 2026

Infection Incidence and Survival in Patients With Multiple Myeloma and Chronic Lymphocytic Leukaemia: A Growing Concern in the Era of Modern Therapies.

Infection Incidence and Survival in Patients With Multiple Myeloma and Chronic Lymphocytic Leukaemia: A Growing Concern in the Era of Modern Therapies.

Journal: EJHaem

Published: February 05, 2026

Comprehensive cancer care in the Nordic countries; Strengths, opportunities and improvement profiles.

Comprehensive cancer care in the Nordic countries; Strengths, opportunities and improvement profiles.

Journal: Journal of cancer policy

Published: January 31, 2026

Survival in mantle cell lymphoma patients burdened by a second primary malignancy.

Survival in mantle cell lymphoma patients burdened by a second primary malignancy.

Journal: Leukemia & lymphoma

Published: January 09, 2026

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma.

Journal: Blood advances

Published: October 31, 2025

Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma.

Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma.

Journal: International journal of cancer

Published: October 01, 2025

Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA.

Complications and clinical outcomes of retroperitoneal lymph node dissection for testicular cancer in a centralized population-based cohort in Sweden: insights from SWENOTECA.

Journal: Scandinavian journal of urology

Published: September 23, 2025

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group.

Journal: British journal of cancer

Published: September 12, 2025

Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma.

Accumulation of high-risk genetic features after chemoimmunotherapy: A longitudinal study in mantle cell lymphoma.

Journal: Leukemia

Published: September 03, 2025

Showing 1-12 of 130

Last Updated: 09/26/2026